Clinical Trials Directory

Trials / Completed

CompletedNCT06307821

the Role of Probiotic in Protein Metabolism

Assessing the Impact of Weizmannella Coagulans BC99 on Protein Digestion and Metabolism: A Randomized, Double-Blind Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Wecare Probiotics Co., Ltd. · Industry
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study investigates the functional effects of probiotics on athletes by administering Weizmannella coagulans BC99 for 12 weeks. It aims to assess the probiotic's influence on skeletal muscle content, athletic performance, and protein digestion and metabolism. This is achieved by monitoring changes in digestive enzymes, amino acids, body composition, and hormone levels. The research seeks to offer a theoretical foundation for optimizing athletes' training and nutrition strategies and suggests the potential of probiotics in enhancing nutrient absorption and utilization, particularly in individuals with compromised digestive capabilities.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticThe intervention lasts for 12 weeks, with follow-ups conducted at weeks 0, 6, and 12 to assess participants' digestion and absorption rates of dietary protein, as well as to collect fecal samples for analysis of changes in the gut microbiota.
DIETARY_SUPPLEMENTPlaceboThe intervention lasts for 12 weeks, with follow-ups conducted at weeks 0, 6, and 12 to assess participants' digestion and absorption rates of dietary protein, as well as to collect fecal samples for analysis of changes in the gut microbiota.

Timeline

Start date
2024-02-25
Primary completion
2024-04-25
Completion
2024-07-30
First posted
2024-03-13
Last updated
2025-10-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06307821. Inclusion in this directory is not an endorsement.